Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Maximum Tolerated Dose of Mesenchymal Stem Cells From Umbilical

NCT03357770 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT03357770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03357770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Maximum Tolerated Dose of Mesenchymal Stem Cells From Umbilical
Lead sponsor
Peking University People's Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2018
Completion date
June 1, 2021
Enrollment
9 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthritis, umbilical cord bleeding